Ardelyx Inc

Stock Chart, Company Information, and Scan Results

$4.27(as of Jul 29, 1:35 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ardelyx Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$4.27
Ticker SymbolARDX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees395
CountyUSA
Market Cap$1,026.4M
EBIDTA-37.4M
10-Day Moving Average4.42
P/E Ratio-19.00
20-Day Moving Average4.39
Forward P/E Ratio0.00
50-Day Moving Average4.01
Earnings per Share-0.23
200-Day Moving Average4.91
Profit Margin-55.51%
RSI51.03
Shares Outstanding239.3M
ATR0.19
52-Week High7.18
Volume3,170,716
52-Week Low3.21
Most Recent Support Level4.21
Book Value145.7M
Most Recent Resistance Level4.48
P/B Ratio7.01
Upper Keltner4.82
P/S Ratio2.82
Lower Keltner3.95
Debt-to-Equity Ratio4.82
Next Earnings Date07/30/2025
Cash Surplus-45.0M
Next Ex-Dividend DateUnknown

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ardelyx Inc In Our Stock Scanner

As of Jul 29, 2025
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.